Therapeutic form of arsenic is a potential treatment for deadly type of brain cancer

(The Translational Genomics Research Institute) In a study led by Northwestern University Feinberg School of Medicine and the Translational Genomics Research Institute (TGen), this anti-cancer agent is being considered for use against glioblastoma multiforme (GBM), the most common and aggressive type of deadly brain tumors. The study was published today in Molecular Cancer Research, a journal of the American Association for Cancer Research (AACR).
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news